Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Opus Genetics (IRD) Debt Ratio (2019 - 2026)

Opus Genetics has reported Debt Ratio over the past 5 years, most recently at 0.02 for Q1 2026.

  • Quarterly Debt Ratio fell 93.2% to 0.02 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.02 through Mar 2026, down 93.2% year-over-year, with the annual reading at 0.02 for FY2025, N/A changed from the prior year.
  • Debt Ratio was 0.02 for Q1 2026 at Opus Genetics, down from 0.02 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.62 in Q3 2025 and troughed at 0.0 in Q3 2023.
  • The 4-year median for Debt Ratio is 0.02 (2025), against an average of 0.18.
  • The largest YoY upside for Debt Ratio was 93.2% in 2026 against a maximum downside of 93.2% in 2026.
  • A 4-year view of Debt Ratio shows it stood at 0.01 in 2022, then plummeted by 83.65% to 0.0 in 2023, then surged by 1209.37% to 0.02 in 2025, then dropped by 20.17% to 0.02 in 2026.
  • Per Business Quant, the three most recent readings for IRD's Debt Ratio are 0.02 (Q1 2026), 0.02 (Q4 2025), and 0.62 (Q3 2025).